Noxzema Brand Overview and Corporate Structure
The Noxzema model operates as a legacy personal care brand focused on facial cleansers and cold cream, historically positioned as a dermatologist-recommended skincare line. The brand is currently owned by Beiersdorf AG, a publicly traded German company headquartered in Hamburg, which maintains a portfolio of skincare and consumer health assets. Beiersdorf AG reports consolidated financials in its annual filings, with Noxzema contributing to the company's Consumer division revenue stream. The brand's market presence is primarily concentrated in North America, where it competes in the mass-market facial cleanser category against products from Unilever, Procter & Gamble, and Kao Corporation. Noxzema's product portfolio includes cleansers, moisturizers, and makeup removers, with the original Cold Cream remaining a flagship SKU. The brand's distribution spans major retailers, drugstore chains, and e-commerce platforms, reflecting a traditional mass-market model within the broader skincare industry. Industry data on mass-market skincare competition
Beiersdorf AG's financial reporting structure groups Noxzema under its Consumer segment, which generated specific revenue figures in the company's latest annual report. The segment includes other brands such as Eucerin, Aquaphor, and Labello, with Noxzema representing a smaller but historically significant portion of the portfolio. Beiersdorf's fiscal year ends on December 31, and the company publishes detailed segment breakdowns in its annual and quarterly reports filed with regulatory authorities. The Noxzema model within Beiersdorf's structure relies on brand heritage and legacy consumer recognition rather than heavy digital-native marketing. The brand's pricing strategy remains in the affordable mass-market tier, targeting value-conscious consumers seeking basic skincare functionality. Beiersdorf's ownership of Noxzema provides the brand with global supply chain and distribution advantages that independent startups cannot easily replicate. Beiersdorf AG SEC filings and annual reports
Noxzema Revenue and Market Performance Metrics
Specific revenue figures for the Noxzema brand alone are not separately disclosed by Beiersdorf in its public financial reports, as the company aggregates sales data at the segment level. The Consumer segment's total revenue, which includes Noxzema, is reported in Beiersdorf's annual financial statements, with the segment contributing a measurable portion of consolidated sales. Market research estimates place the facial cleanser category, where Noxzema competes, at several billion dollars in annual global retail sales. Noxzema's market share within this category is modest compared to leading brands, but the brand maintains a loyal customer base that values its traditional formulation and affordable price point. The brand's sales trajectory has been influenced by shifts in consumer preferences toward minimalist skincare routines and natural ingredient-focused products. Noxzema's distribution performance is tracked through retail partner sell-through data and syndicated market research services that monitor mass-market skincare categories. Skincare market size and growth statistics
The Noxzema model's financial performance is impacted by raw material costs, currency fluctuations, and competitive pressures from both established and emerging skincare brands. Beiersdorf's annual reports provide segment-level operating profit margins, which reflect the combined performance of Noxzema alongside other Consumer division brands. The company's cost structure includes manufacturing, logistics, marketing, and research expenses, with Noxzema benefiting from Beiersdorf's centralized R&D capabilities. Retail pricing for Noxzema products remains in the lower-to-mid range of the facial cleanser market, positioning the brand as